title: Powered for success: considerations for using the candidate gene approach in rheumatic diseases in the post-genomics era.
authors.affiliation: Senior Research Scientist;
authors.forename: Darren D
authors.initials: DD
authors.lastname: O'Rielly
authors.affiliation: Associate Professor, Discipline of Genetics.
authors.forename: Guangju
authors.initials: G
authors.lastname: Zhai
authors.affiliation: University Research Professor, Faculty of Medicine, Memorial University, St. John's, Newfoundland, Canada. prahman@mun.ca.
authors.forename: Proton
authors.initials: P
authors.lastname: Rahman
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood* / Q000235:genetics*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha